Polen Capital Management »

Urogen Pharma shares owned by Polen Capital Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Polen Capital Management from 13F filings

Historical chart of Polen Capital Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Polen Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Polen Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1M 30k 36.80

More positions owned by Polen Capital Management

Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Amazon (AMZN)
Visa Com Cl A (V)
Mastercard Incorporated Cl A (MA)
Servicenow (NOW)
Oracle Corporation (ORCL)
Shopify Cl A Sub Vtg Shs (SHOP)
Msci (MSCI)
Lam Research Corp Com New (LRCX)
Starbucks Corporation (SBUX)
IDEXX Laboratories (IDXX)

View all positions for Polen Capital Management

Top funds holding Urogen Pharma

Rtw Investments
BlackRock
Morgan Stanley
Kynam Capital Management
Leucadia National Corporation
SG Americas Securities
American Century Companies
Acorn Capital Advisors
Point72 Asset Management
Frontier Capital Management
Opaleye Management
Silverarc Capital Management
Menora Mivtachim Holdings
D. E. Shaw & Co
MPM Oncology Impact Management

View all funds holding Urogen Pharma